Author

Lebohang Molife

International AIDS Vaccine Initiative

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

Agnes M. Harskamp· 1 shared Aimee A. DesrosiersiD· 1 shared Albert CupoiD· 1 shared Alessia Noto· 1 shared Alex C. Sullivan· 1 shared Alexandra Rogue· 1 shared Alexis Menard· 1 shared Alicia SatoiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Agnes M. Harskamp

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintOct 26, 2026

Sequential vaccination matures VRC01-class HIV-1 neutralizing antibodies in humans

Tom G. Caniels, Madhu S. Prabhakaran, Sashank Agrawal…·Rogier W. Sanders

This study shows that sequential vaccination can mature VRC01-class B cells into antibodies that neutralize a broad range of HIV-1 viruses.

DOI 10.64898/2026.10.21.760679

humanproteomics

𝕏 PostBluesky

Pharmacology & ToxicologyVaccinesPeer-reviewedFeb 6, 2026

Non-clinical safety of GRAd vector-based COVID-19 and HIV vaccines supports a platform regulatory approach

Reji Paalangara, Stéphanie Gohin, Alexis Menard…·Stefania Capone

This study evaluates the non-clinical safety of two GRAd vector-based vaccines for COVID-19 and HIV, showing consistent safety profiles and supporting a regulatory platform approach.

2 citationstop 4%

𝕏 PostBluesky